Presbyterian/St. Luke's Medical Center, Denver

Academic/Hospital

Also known as: Blood and Marrow Transplant Program, Colorado Blood Cancer Institute, Presbyterian/St. Luke's Medical Center, Denver | Blood and Marrow Transplant Program, Presbyterian/St. Luke's Medical Center, Rocky Mountain Cancer Center

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

Jun 1, 2005

Last known activity

Jul 1, 2006

Timeline

No events for the selected filters.

Drugs by trial phase (11 distinct, 2 trials)

Phase 3 (5 own, 0 via acquisition)

methylprednisolone
lymphocyte immune globulin, anti-thymocyte globulin (equine)
cyclophosphamide
autologous mononuclear stem cell
sargramostim

Phase 2 (6 own, 0 via acquisition)

prednisone
carmustine
etoposide
cytarabine
melphalan
autologous hematopoietic stem cells

Indications

Studied for

Autoimmune Diseases
Multiple Sclerosis
Multiple Sclerosis, Relapsing-Remitting
Scleroderma, Diffuse
Scleroderma, Systemic
Sclerosis

Recent trials (2)

NCT00288626Study chairPhase 2Jul 1, 2006
NCT00114530Study chairPhase 2/Phase 3Jun 1, 2005

Details

Last known activity: Jul 1, 2006